Application of Acupoint Pressing Stimulation in Relieving Postoperative Nausea and Vomiting in Patients Undergoing Gynecological Surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200067239

Enrollment

Unknown

Registered

2022-12-30

Start date

2021-01-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting

Interventions

Press acupuncture point stimulation group:Press needle to stimulate acupoints

Press acupuncture point stimulation combined with dexamethasone 5mg group:Press needle to stimulate acupoints+dexamethasone 5mg

Press acupuncture point stimulation combined with dexamethasone 10mg group:Press needle to stimulate acupoints+dexamethasone 10mg

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients planning to undergo gynecological surgery. 2. Don't smoke. 3. Patients with a history of motion sickness. 4. Patients with intraoperative opiates. 5. Patients aged between 18 and 65 years. 6. ASA grading ?-?.

Exclusion criteria

Exclusion criteria: 1. Patients who refuse acupoint stimulation. 2. Patients with antiemetic drugs. 3. Patients who refused to sign the consent form. 4. Patients with mental disorders and inability to communicate. 5. Allergic to adhesive tape and snap needle. 6. Patients with diabetes.

Design outcomes

Primary

Measure	Time frame
Incidence of nausea and vomiting;	—

Countries

China

Contacts

Public ContactGao Hongliang

Hebei Traditional Chinese Medicine Hospital

305387506@qq.com+86 15932118480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026